» Articles » PMID: 29291244

Unveiling Massive Numbers of Cancer-related Urinary-microRNA Candidates Via Nanowires

Abstract

Analyzing microRNAs (miRNAs) within urine extracellular vesicles (EVs) is important for realizing miRNA-based, simple, and noninvasive early disease diagnoses and timely medical checkups. However, the inherent difficulty in collecting dilute concentrations of EVs (<0.01 volume %) from urine has hindered the development of these diagnoses and medical checkups. We propose a device composed of nanowires anchored into a microfluidic substrate. This device enables EV collections at high efficiency and in situ extractions of various miRNAs of different sequences (around 1000 types) that significantly exceed the number of species being extracted by the conventional ultracentrifugation method. The mechanical stability of nanowires anchored into substrates during buffer flow and the electrostatic collection of EVs onto the nanowires are the two key mechanisms that ensure the success of the proposed device. In addition, we use our methodology to identify urinary miRNAs that could potentially serve as biomarkers for cancer not only for urologic malignancies (bladder and prostate) but also for nonurologic ones (lung, pancreas, and liver). The present device concept will provide a foundation for work toward the long-term goal of urine-based early diagnoses and medical checkups for cancer.

Citing Articles

Nanobiodevices and quantum life science for future healthcare.

Shimada T, Yasui T, Yukawa H, Baba Y Anal Sci. 2025; .

PMID: 40035948 DOI: 10.1007/s44211-025-00742-8.


High throughput analysis of rare nanoparticles with deep-enhanced sensitivity via unsupervised denoising.

Iwamoto Y, Salmon B, Yoshioka Y, Kojima R, Krull A, Ota S Nat Commun. 2025; 16(1):1728.

PMID: 39979247 PMC: 11842628. DOI: 10.1038/s41467-025-56812-y.


Extracellular vesicles as a promising biomarker resource in liquid biopsy for cancer.

Tamura T, Yoshioka Y, Sakamoto S, Ichikawa T, Ochiya T Extracell Vesicles Circ Nucl Acids. 2024; 2(2):148-174.

PMID: 39703905 PMC: 11656527. DOI: 10.20517/evcna.2021.06.


Liquid biopsy for monitoring medulloblastoma.

Eibl R, Schneemann M Extracell Vesicles Circ Nucl Acids. 2024; 3(3):280-291.

PMID: 39697492 PMC: 11648495. DOI: 10.20517/evcna.2022.36.


Early Cancer Detection via Multi-microRNA Profiling of Urinary Exosomes Captured by Nanowires.

Yasui T, Natsume A, Yanagida T, Nagashima K, Washio T, Ichikawa Y Anal Chem. 2024; 96(43):17145-17153.

PMID: 39422334 PMC: 11525924. DOI: 10.1021/acs.analchem.4c02488.


References
1.
Edgar J . Q&A: What are exosomes, exactly?. BMC Biol. 2016; 14:46. PMC: 4906597. DOI: 10.1186/s12915-016-0268-z. View

2.
Schlappi T, McCalla S, Schoepp N, Ismagilov R . Flow-through Capture and in Situ Amplification Can Enable Rapid Detection of a Few Single Molecules of Nucleic Acids from Several Milliliters of Solution. Anal Chem. 2016; 88(15):7647-53. DOI: 10.1021/acs.analchem.6b01485. View

3.
Jeppesen D, Hvam M, Primdahl-Bengtson B, Boysen A, Whitehead B, Dyrskjot L . Comparative analysis of discrete exosome fractions obtained by differential centrifugation. J Extracell Vesicles. 2014; 3:25011. PMC: 4224706. DOI: 10.3402/jev.v3.25011. View

4.
Lu Y, Cheng A, Lee L, You G, Li Y, Chen H . MiR-520b as a novel molecular target for suppressing stemness phenotype of head-neck cancer by inhibiting CD44. Sci Rep. 2017; 7(1):2042. PMC: 5435724. DOI: 10.1038/s41598-017-02058-8. View

5.
Shen Q, Xu L, Zhao L, Wu D, Fan Y, Zhou Y . Specific capture and release of circulating tumor cells using aptamer-modified nanosubstrates. Adv Mater. 2013; 25(16):2368-73. PMC: 3786685. DOI: 10.1002/adma.201300082. View